Loading…
Mindray (Shenzhen, China) announced its intention to acquire control of APT Medical (Shenzhen, China), a cardiovascular medical device company, for $927 million using its own funds via share transfer and waiver of voting rights.
“Mindray will acquire control of APT Medical using its own funds of USD 927 million using a combination of share transfer by agreement and waiver of voting rights.”gzjiayumed.com
Summarized from public sources; check the original articles before acting on it.